| Literature DB >> 33269414 |
Stephen Rajan Samuel1, Rachita Gururaj1, K Vijaya Kumar2, Prina Vira1, P U Prakash Saxena3, Justin William Leslie Keogh1,4,5,6.
Abstract
PURPOSE: Cancer survivors may experience sleep disturbances during and after their cancer treatments. While pharmacological approaches are commonly used to address sleep disturbances, they may have a number of adverse effects. This review studied the effect of two non-pharmacological interventions (massage and relaxation therapy) on sleep disturbances in cancer survivors.Entities:
Keywords: Carcinoma; Massage; Relaxation therapy; Sleep wake disorders
Mesh:
Year: 2020 PMID: 33269414 PMCID: PMC8448699 DOI: 10.1007/s11764-020-00972-x
Source DB: PubMed Journal: J Cancer Surviv ISSN: 1932-2259 Impact factor: 4.442
Fig. 1PRISMA flowchart describing the study selection process
Fig. 2a Risk of bias of massage therapy studies. Green - low risk, yellow - unclear risk, and red - high risk of bias. b Risk of bias of relaxation therapy studies
Summary of massage therapy studies
| Reference | Sample | Intervention details | Results | ||||
|---|---|---|---|---|---|---|---|
| Cancer type and stage | Age, sex, and sample size | Cancer treatment and sleep disorder status | Description | Duration and frequency | Pre | Post | |
| Jane et al. 2011 [ | Mixed cancer type, stage 4 patients with metastatic bone cancer | 50.1 ± 11.5 yr (15 M, 21 F) | Cancer treatment: completed primary treatment, with 56% under palliative care; sleep disorder: not stated | Effleurage, light petrissage, compression, and nerve stroke to total body, provided by cancer nurses with 3 months of massage training. | 45 min for 3 days | RCSQ (T1): 22.1 ± 15.1 | RCSQ (T3): 32.8 ± 11.4# |
49.7 ± 9.7 yr (15 M, 21 F) | Social attention encouraging participants to express feelings or concerns about admission involving the presence of a caring therapist | RCSQ (T1): 25.1 ± 13.6 | RCSQ (T3): 30.2 ± 14.4 | ||||
| Toth et al. 2013 [ | Mixed (stage 4) patients with metastatic cancer | 54.9 ± 12 yr (3 M, 17 F) | Cancer treatment: not stated; Sleep disorder: not stated. | Swedish and non-Swedish massage techniques including gliding/effleurage, light petrissage, compression, and nerve stroke to non-metastatic areas provided by professional massage therapists | 15–45 min/day, 3 daysa week for 1 week | RCSQ CS (1 week): − 3.5 (− 9, 0) RCSQ CS (1 month): − 4 (− 12, 0) | |
54.9 ± 10 yr (1 M, 9 F) | No-touch control provided by professional massage therapists with hands 12 in. (30 cm) above participants but with no healing intention | RCSQ CS (1 week): 0 (− 7, 9) RCSQ CS (1 month): 0 (− 12, 10) | |||||
55.6 ± 9 yr (3 M, 6 F) | Usual care participants received no visits from massage therapists | RCSQ CS (1 week): − 0.5 (− 4, 1) RCSQ CS (1 month): 0 (− 15, 12) | |||||
| Jacobs et al. 2016 [ | Mixed type and stage with at least 4 days of hospitalization | 15.5 ± 2.6 yr (12 M, 4 F) | Cancer treatment: 70% receiving chemotherapy. Sleep disorder: not stated. | Swedish massage of the total body by massage therapists | 20–30 min/day for 2–3 days | Pre- (outcome mean) SMN: 366 SEN: 59 WM: 259 WE :18 LSE: 11 24SM: 391 24SE: 13 | Post- (outcome mean) SMN: 419 SEN: 64 WM: 258 WE: 19 LSE: 12* 24SM: 444 24SE: 17 |
16 ± 2.5 yr (12 M, 6 F) | Usual care received no special treatment other than the primary chemotherapy treatment. | SMN: 379 SEN: 63 WM: 247 WE: 20 LSE: 13 24SM: 431 24SE: 18 | SMN: 365 SEN: 67 WM: 194 WE: 16 LSE :11 24SM: 401 24SE: 16 | ||||
| Miladina et al. 2017 [ | Acute leukemia undergoing chemotherapy | 33.9 ± 9.6 yr (16 M, 14 F) | Cancer treatment: chemotherapy; Sleep disorder: ≥ 3 on Numerical Rating Scale and > 5 on PSQI | Slow-stroke back massage involving circular, sweeping hand strokes extending from the skull to sacrum by oncology nurses with 4 months of massage training. | 10 min/day, 3 days a week for 4 weeks | PSQI Pre: 12.23 ± 3.75 | PSQI Post: 9.70 ± 3.27* |
35.1 ± 9.6 yr (15 M, 15 F) | Usual care routine nursing and medical care | 12.10 ± 3.45 | 12.37 ± 3.43 | ||||
CS change score, F females, LSE long sleep episodes at nighttime, M males, PSQI Pittsburgh Sleep Quality Index, RCSQ Richards-Campbell Sleep Questionnaire, SEN sleep efficiency at nighttime, SMN sleeping minutes at nighttime, t1 first session, t3 third session, WE wake episodes during sleep at nighttime, WM wake min after sleep onset at nighttime, yr years, 24SE long sleep episodes through whole day, 24SM sleeping minutes through the whole day
*Statistically significant (p < 0.05) between-group improvement
#Statistically significant (p < 0.05) within-group improvement
Summary of relaxation therapy studies
| Reference | Sample | Intervention details | Results | |||||
|---|---|---|---|---|---|---|---|---|
| Cancer type and stage | Age, sex and sample size | Cancer treatment and sleep disorder status | Description | Duration and frequency | Pre | Mid | Post | |
| Ducloux et al. 2012[ | Mixed (stage 4) with metastatic cancer and estimated prognosis < 6 months | 61 ± 15 yr (3 M, 6 F) | Cancer treatment: not stated; Sleep disorder: diagnosed using ICSD criteria. | Immediate intervention: Deep breathing exercises, somatic tension release was taught by a specialized nurse with certification in relaxation. An audio recording of the program on CD was provided to the participants to use prior to nighttime sleep. | 1 h/day for 3 days | NRSSS day 1: 6.1 + 2.4 | NRSSS day 2: 3.6 ± 2.3 | NRSSS day 5: 4.0 ± 2.3 |
66 ± 12 yr (3 M, 6 F) | Delayed intervention: as above, but started 3 days after the immediate intervention group. | 6.5 + 2.2 | 4.0 ± 2.1 | 3.8 ± 2.3 | ||||
| Nooner et al. 2016 [ | Hematologic malignancies or solid tumors, undergoing chemotherapy or prior to HSCT | 45 ± 18 yr (6 M, 5 F) | Cancer treatment: chemotherapy and pre-HSCT therapy; Sleep disorder: not stated. | Guided imagery: 19-min audio program-morning exercise, which guides the listener through waking in the morning. | 19 to 39 min/day for 60 days | PROMIS sleep baseline: Pt.5: 23/40 Pt.7: 19/40 Pt.9: 25/40 | PROMIS sleep day 30: 21/40 17/40 29/40 | PROMIS sleep day 60: - 20/40 - |
| Relaxation: 39-min audio program guide to serenity which guided the listener through a 10-point system of progressive relaxation. | Pt.2: 25/40 Pt.3: 35/40 Pt.10: 27/40 | 20/40 - - | 26/40 - - | |||||
| Relaxation + guided imagery - received both. | Pt.1: 28/40 Pt.8: 25/40 Pt.12: 17/40 | - 22/40 21/40 | - 20/40 19/40 | |||||
| Usual care: received usual medical care but were given relaxation video resources used in the intervention after study was completed. | Pt.4: 22/40 Pt.6: - Pt.11: 20/40 | 21/40 - - | - - - | |||||
| Zupanec et al. 2017 [ | Children with ALL undergoing maintenance chemotherapy | 6.3 ± 1.8 yr (10 M, 1 F) | Cancer treatment: Maintenance- chemotherapy; Sleep disorder: excluded from study if they had a physician- diagnosed sleep disorder such as insomnia or restless leg syndrome. | Education and children’s books to promote relaxation using deep breathing and progressive muscle relaxation; facilitated by 2 registered nurses who had completed an 8-h training course on sleep hygiene and relaxation techniques | 4 weeks | NS: 456 ± 105 LSNS: 120 ± 32 DS: 42 ± 27 LSDS: 28 ± 19 WTASO: 117 ± 44 NNA: 16 ± 4 CSHQ: 50 ± 8 | - | NS: 498 ± 65 LSNS: 129 ± 44 DS: 32 ± 51 LSDS: 17 ± 28 WTASO: should 99 ± 47 NNA: 17 ± 5 CSHQ: 48 ± 8 |
6.2 ± 2.0 yr (8 M, 1 F) | Usual care - advised to continue usual clinical activities. | NS: 488 ± 36 LSNS: 135 ± 28 DS: 21 ± 17 LSDS: 16 ± 12 WTASO:75 ± 39 NNA: 16 ± 3 CSHQ: 49 ± 6 | - | NS: 495 ± 59 LSNS: 134 ± 89 DS: 11 ± 14 LSDS: 5 ± 7 WTASO:106 ± 43 NNA: 18 ± 6 CSHQ: 48 ± 6 | ||||
ALL acute lymphoblastic leukemia, CSHQ Children sleep habits questionnaire, DS Daytime sleep, F females, ICSD International Classification of Sleep Disorders, LSDS longest stretch of daytime sleep, LSNS longest stretch of nighttime sleep, M males, NNA number of nighttime awakenings, NRSSS Numerical Rating Scale of Satisfaction of Sleep, NS Nighttime sleep, PROMIS Patient-Reported Outcomes Measurement Information System, Pt participant, WTASO wake time after sleep onset, yr years
□No face-to-face therapist guidance appeared to be provided to the intervention participants